180 related articles for article (PubMed ID: 36243020)
1. Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.
Spinazzi EF; Argenziano MG; Upadhyayula PS; Banu MA; Neira JA; Higgins DMO; Wu PB; Pereira B; Mahajan A; Humala N; Al-Dalahmah O; Zhao W; Save AV; Gill BJA; Boyett DM; Marie T; Furnari JL; Sudhakar TD; Stopka SA; Regan MS; Catania V; Good L; Zacharoulis S; Behl M; Petridis P; Jambawalikar S; Mintz A; Lignelli A; Agar NYR; Sims PA; Welch MR; Lassman AB; Iwamoto FM; D'Amico RS; Grinband J; Canoll P; Bruce JN
Lancet Oncol; 2022 Nov; 23(11):1409-1418. PubMed ID: 36243020
[TBL] [Abstract][Full Text] [Related]
2. Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
Thompson EM; Landi D; Brown MC; Friedman HS; McLendon R; Herndon JE; Buckley E; Bolognesi DP; Lipp E; Schroeder K; Becher OJ; Friedman AH; McKay Z; Walter A; Threatt S; Jaggers D; Desjardins A; Gromeier M; Bigner DD; Ashley DM
Lancet Child Adolesc Health; 2023 Jul; 7(7):471-478. PubMed ID: 37004712
[TBL] [Abstract][Full Text] [Related]
3. Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.
Sonabend AM; Stuart RM; Yun J; Yanagihara T; Mohajed H; Dashnaw S; Bruce SS; Brown T; Romanov A; Sebastian M; Arias-Mendoza F; Bagiella E; Canoll P; Bruce JN
Neuro Oncol; 2011 Aug; 13(8):886-93. PubMed ID: 21750007
[TBL] [Abstract][Full Text] [Related]
4. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
[TBL] [Abstract][Full Text] [Related]
5. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
[TBL] [Abstract][Full Text] [Related]
6. Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Sonabend AM; Gould A; Amidei C; Ward R; Schmidt KA; Zhang DY; Gomez C; Bebawy JF; Liu BP; Bouchoux G; Desseaux C; Helenowski IB; Lukas RV; Dixit K; Kumthekar P; Arrieta VA; Lesniak MS; Carpentier A; Zhang H; Muzzio M; Canney M; Stupp R
Lancet Oncol; 2023 May; 24(5):509-522. PubMed ID: 37142373
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
[TBL] [Abstract][Full Text] [Related]
9. Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.
D'Amico RS; Neira JA; Yun J; Alexiades NG; Banu M; Englander ZK; Kennedy BC; Ung TH; Rothrock RJ; Romanov A; Guo X; Zhao B; Sonabend AM; Canoll P; Bruce JN
J Neurosurg; 2019 Aug; 133(3):614-623. PubMed ID: 31374547
[TBL] [Abstract][Full Text] [Related]
10. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
Pöpperl G; Goldbrunner R; Gildehaus FJ; Kreth FW; Tanner P; Holtmannspötter M; Tonn JC; Tatsch K
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1018-25. PubMed ID: 15877226
[TBL] [Abstract][Full Text] [Related]
11. Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.
Grahn AY; Bankiewicz KS; Dugich-Djordjevic M; Bringas JR; Hadaczek P; Johnson GA; Eastman S; Luz M
J Neurooncol; 2009 Nov; 95(2):185-197. PubMed ID: 19466380
[TBL] [Abstract][Full Text] [Related]
12. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.
Barua NU; Hopkins K; Woolley M; O'Sullivan S; Harrison R; Edwards RJ; Bienemann AS; Wyatt MJ; Arshad A; Gill SS
Drug Deliv; 2016; 23(1):167-73. PubMed ID: 24786643
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Baize N; Monnet I; Greillier L; Geier M; Lena H; Janicot H; Vergnenegre A; Crequit J; Lamy R; Auliac JB; Letreut J; Le Caer H; Gervais R; Dansin E; Madroszyk A; Renault PA; Le Garff G; Falchero L; Berard H; Schott R; Saulnier P; Chouaid C;
Lancet Oncol; 2020 Sep; 21(9):1224-1233. PubMed ID: 32888454
[TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced drug delivery for glioblastoma: a review.
D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN
J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
Wang JL; Barth RF; Cavaliere R; Puduvalli VK; Giglio P; Lonser RR; Elder JB
PLoS One; 2020; 15(12):e0244383. PubMed ID: 33373402
[TBL] [Abstract][Full Text] [Related]
17. Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma.
Bander ED; Ramos AD; Wembacher-Schroeder E; Ivasyk I; Thomson R; Morgenstern PF; Souweidane MM
J Neurosurg Pediatr; 2020 Sep; 26(6):661-666. PubMed ID: 32977309
[TBL] [Abstract][Full Text] [Related]
18. Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.
Bruce JN; Fine RL; Canoll P; Yun J; Kennedy BC; Rosenfeld SS; Sands SA; Surapaneni K; Lai R; Yanes CL; Bagiella E; DeLaPaz RL
Neurosurgery; 2011 Dec; 69(6):1272-9; discussion 1279-80. PubMed ID: 21562434
[TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
Saito R; Krauze MT; Noble CO; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
Neuro Oncol; 2006 Jul; 8(3):205-14. PubMed ID: 16723630
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group.
Macdonald D; Cairncross G; Stewart D; Forsyth P; Sawka C; Wainman N; Eisenhauer E
Ann Oncol; 1996 Feb; 7(2):205-7. PubMed ID: 8777179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]